Helius Medical Technologies Inc (HSDT)
GeoVax Labs Inc. (GOVX)
Rocket Pharmaceuticals Inc (RCKT)
Rocket Pharmaceuticals Presents Preliminary Data from Phase 1 Clinical Trial of RP-A601 for PKP2 Arrhythmogenic Cardiomyopathy at 28th Annual Meeting of the American Society of Gene and Cell Therapy